Clinical trial
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
NCT01944371
Study timeline
Study start (unknown)2013-09-01Date precision: month
Registry last updated2020-05-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIVunresolved
Human Immunodeficiency Virusunresolved
Interventions
DisulfiramDRUG · verified · RxNorm: disulfiram
Sponsors & collaborators
University of California, San Franciscolead sponsor
Monash Universitycollaborator
amfAR, The Foundation for AIDS Researchcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01944371 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.